Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Invested Capital (2016 - 2026)

Cryo Cell International's Invested Capital history spans 17 years, with the latest figure at -$16.8 million for Q1 2026.

  • Quarterly results put Invested Capital at -$16.8 million for Q1 2026, down 66.57% from a year ago — trailing twelve months through Feb 2026 was -$16.8 million (down 66.57% YoY), and the annual figure for FY2025 was -$16.3 million, down 68.17%.
  • Invested Capital for Q1 2026 was -$16.8 million at Cryo Cell International, down from -$16.3 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $4.4 million in Q2 2022 to a low of -$16.8 million in Q1 2026.
  • The 5-year median for Invested Capital is -$7.3 million (2024), against an average of -$5.5 million.
  • The sharpest move saw Invested Capital surged 350.8% in 2022, then crashed 1410.55% in 2023.
  • Year by year, Invested Capital stood at $748426.0 in 2022, then crashed by 1410.55% to -$9.8 million in 2023, then increased by 1.15% to -$9.7 million in 2024, then crashed by 68.17% to -$16.3 million in 2025, then fell by 3.03% to -$16.8 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$16.8 million, -$16.3 million, and -$11.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.